VCA Antech Inc: Company Profile and SWOT Analysis

Document Sample
VCA Antech Inc: Company Profile and SWOT Analysis Powered By Docstoc
					VCA Antech Inc

_________________________________________________________________________________



VCA Antech Inc                                                                Financial Snapshot

                                                                              Operating Performance
Fast Facts
                                    12401 West Olympic Boulevard, Los         The company reported revenue of US$1,381.47
Headquarters Address
                                    Angeles, 90064,United States of America   million during the fiscal year 2010 (2010). The
                                                                              company's revenue grew at a CAGR of 8.87% during
Telephone                           + 1 310 5716500
                                                                              2006–2010, with an annual growth of 5.09% over
                                                                              2009. In 2010, the company recorded an operating
Fax                                 + 1 310 5716700                           margin of 14.85%, as against 18.37% in 2009.

Website                             www.vcaantech.com
                                                                              Revenue and Margins
Ticker Symbol, Stock Exchange       WOOF, NASDAQ

Number of Employees                 8,500

Fiscal Year End                     December

Revenue (in US$ million)            1,381.47




SWOT Analysis

Strengths                           Weaknesses                                Return on Equity

Comprehensive Veterinary Services   Declining Margins                         The company recorded a return on equity (ROE) of
                                                                              11.04% for 2010, as compared to its peers, PetMed
                                                                              Express, Inc. (Ticker: PETS), IDEXX Laboratories,
Efficient Use of Resources          Highly Leveraged                          Inc. (Ticker: IDXX) and PetSmart, Inc. (Ticker:
                                                                              PETM), which recorded ROEs of 26.85%, 24.60%
Strong Technology Offering                                                    and 16.91% respectively. The company reported an
                                                                              operating margin of 14.85% in 2010.
Opportunities                       Threats
                                                                              Return on Equity
Growing Veterinary Market           Government Regulations

Highly Fragmented Market            Intense Competition

Inorganic Growth Strategy           Seasonality of Business

                                    Shortage of Veterinarians




                                                                              Liquidity Position

                                                                              The company reported a current ratio of 1.74 in 2010,
                                                                              as compared to its peers, PetMed Express, Inc.,
                                                                              IDEXX Laboratories, Inc. and PetSmart, Inc., which
                                                                              recorded current ratios of 12.20, 1.62 and 1.89
                                                                              respectively. As of December 2010, the company
                                                                              recorded cash and short-term investments of worth
                                                                              US$97.13 million, against US$28.10 million current
                                                                              debt. The company reported a debt to equity ratio of
                                                                              0.53 in 2010 as compared to its peers, PetMed
                                                                              Express, Inc., IDEXX Laboratories, Inc. and
                                                                              PetSmart, Inc., which recorded debt to equity ratios of
                                                                              0.00, 0.23 and 0.49 respectively.




___________________________________________________________________________________________

VCA Antech Inc - SWOT Profile                                                                                         Page 1
VCA Antech Inc

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Operational Efficiency ......................................................................................................................................13
      2.2.5       Solvency ..........................................................................................................................................................14
      2.2.6       Valuation ..........................................................................................................................................................15
    2.3       Competitive Benchmarking ..................................................................................................................................16
      2.3.1       Market Capitalization .......................................................................................................................................16
      2.3.2       Efficiency ..........................................................................................................................................................17
      2.3.3       Capital Expenditure ..........................................................................................................................................18
      2.3.4       Valuation ..........................................................................................................................................................19
      2.3.5       Turnover – Inventory and Asset .......................................................................................................................20
3     SWOT Analysis ...........................................................................................................
				
DOCUMENT INFO
Description: ICD Research's "VCA Antech Inc: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.